Nanosonics Ltd. (ASX: NAN) Share Price and News
() Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
Nanosonics Ltd (NAN) was established in 2001 and is best known for its trophon® technology. The trophon device was launched in 2009 and pioneered a new standard for the disinfection of ultrasound probes. The technology is utilised to disinfect intracavity and surface ultrasound probes with the aim of significantly reducing the occurrence of cross contamination between patients.
Nanosonics listed on the ASX in 2007 and by 2015, its market capitalisation had grown so significantly it joined the ASX 300 Index. In just one more year, the continuing rise of the Nanosonics share price would see the company form part of the ASX 200 Index.
Headquartered in Sydney, Nanosonics employs over 200 people and has offices in the United States, Canada, the United Kingdom and Europe.
In 2018, the company launched trophon® 2, the latest innovation in its ultrasound disinfection technology. Nanasonics also manufactures and distributes a range of consumables and accessories that are used as part of the trophon system.
The company is committed to ongoing research and the continuing development of superior disinfection technologies.
Nanosonics Ltd. (ASX: NAN) Latest News
Sebastian Bowen | October 12, 2020 8:43am
Here on our ASX 200 Foolish Weekly Wrap, we look at the things that moved the S&P/ASX 200 Index and the broader share market... More »
James Mickleboro | October 10, 2020 8:20am
Megaport Ltd (ASX:MP1) and Nanosonics Ltd (ASX:NAN) shares were among the worst performers on the ASX 200 last week... More »
Brendon Lau | September 20, 2020 8:50am
Technology darlings have been leading the global market sell-off and have put investors on edge. But the shake-up may be an opportunity to buy... More »
James Mickleboro | September 18, 2020 8:51am
The Nanosonics Ltd (ASX:NAN) share price has fallen 14% in the last few weeks. Is this a buying opportunity for investors? More »
Brendon Lau | September 17, 2020 3:54pm
The Cyclopharm Limited (ASX: CYC) share price continues to bask in the glory of its clinical trial announcement released earlier this week. More »
Brendon Lau | September 15, 2020 4:23pm
The Rhinomed Ltd (ASX: RNO) share price surged to a six-month high as it takes a leaf out of the Starpharma Holdings Limited (ASX:... More »
Brendon Lau | September 7, 2020 2:58pm
ASX small caps have delivered better FY20 results than their bigger counterparts, but which of these emerging stocks can keep outperforming? More »
James Mickleboro | September 3, 2020 3:15pm
Here's why I think Altium Limited (ASX:ALU) and these ASX 200 shares could be great buy and hold options for Australian investors... More »